0001358403-19-000112.txt : 20190823 0001358403-19-000112.hdr.sgml : 20190823 20190823160417 ACCESSION NUMBER: 0001358403-19-000112 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190821 FILED AS OF DATE: 20190823 DATE AS OF CHANGE: 20190823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Naeve Gregory S. CENTRAL INDEX KEY: 0001714833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 191049166 MAIL ADDRESS: STREET 1: C/O BELLICUM PHARMACEUTICALS, INC. STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800 CITY: HOUSTON STATE: TX ZIP: 77030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201450200 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 4 1 wf-form4_156659064157849.xml FORM 4 X0306 4 2019-08-21 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001714833 Naeve Gregory S. C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030 0 1 0 0 Chief Business Officer Common Stock 2019-08-21 4 F 0 1597 0.9477 D 13746 D Represents the number of shares withheld by and surrendered to the Issuer on August 21, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on August 21, 2017 for 15,000 shares, of which 3,750 vested on August 21, 2019. The RSUs vest in four equal annual installments beginning August 21, 2018. Includes 902 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan on June 10, 2019. /s/ Rosemary Y. Williams, Attorney-in-Fact 2019-08-23